Jagsonpal Pharmaceuticals Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Jagsonpal Pharmaceuticals has allotted 2,96,320 equity shares under ESOP on 04 June 2026. Consequent to the above allotment, the paid-up share capital of the Company has increased from Rs. 13,10,78,300 (constituting of 6,55,39,150 equity shares of Rs. 2/- each) to Rs. 13,16,70,940 (constituting of 6,58,35,470 equity shares of Rs. 2/- each).

Jagsonpal Pharmaceuticals has allotted 1,93,000 equity shares under ESOP on 27 April 2026.

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 27 April 2026, inter alia, have recommended the final dividend of Rs 4 per equity Share (i.e. 200%) , subject to the approval of the shareholders.

Net profit of Jagsonpal Pharmaceuticals rose 33.13% to Rs 8.76 crore in the quarter ended March 2026 as against Rs 6.58 crore during the previous quarter ended March 2025. Sales rose 9.63% to Rs 64.20 crore in the quarter ended March 2026 as against Rs 58.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 22.18% to Rs 43.08 crore in the year ended March 2026 as against Rs 55.36 crore during the previous year ended March 2025. Sales rose 6.89% to Rs 287.23 crore in the year ended March 2026 as against Rs 268.72 crore during the previous year ended March 2025.

Powered by Capital Market - Live News